Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction

Despite current standard of care treatment, the period shortly after acute myocardial infarction (AMI) is associated with high residual cardiovascular (CV) risk, with high rates of recurrent AMI and CV death in the first 90 days following the index event. This represents an area of high unmet need t...

Descripción completa

Detalles Bibliográficos
Autores principales: Korjian, Serge, Kazmi, Syed Hassan A, Chi, Gerald, Kalayci, Arzu, Lee, Jane J, Talib, Usama, Wright, Samuel D, Duffy, Danielle, Kingwell, Bronwyn A, Mehran, Roxana, Ridker, Paul M, Gibson, C Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236524/
https://www.ncbi.nlm.nih.gov/pubmed/36787889
http://dx.doi.org/10.1093/ehjcvp/pvad014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236524/
https://www.ncbi.nlm.nih.gov/pubmed/36787889
http://dx.doi.org/10.1093/ehjcvp/pvad014

Ejemplares similares